Tristar Skyline Medical Center Acute Care Hospital (Medicare Certified) Location: 3441 Dickerson Pike, Nashville, Tennessee 37207 Ratings: Phone: (615) 769-2000 |
Vanderbilt University Medical Center Acute Care Hospital (Medicare Certified) Location: 1211 Medical Center Drive, Nashville, Tennessee 37232 Ratings: Phone: (615) 322-3454 |
Saint Thomas West Hospital Acute Care Hospital (Medicare Certified) Location: 4220 Harding Rd, Po Box 380, Nashville, Tennessee 37205 Ratings: Phone: (615) 222-2111 |
Metro Nashville General Hospital Acute Care Hospital (Medicare Certified) Location: 1818 Albion Street, Nashville, Tennessee 37208 Ratings: Phone: (615) 341-4490 |
Saint Thomas Midtown Hospital Acute Care Hospital (Medicare Certified) Location: 2000 Church St, Nashville, Tennessee 37236 Ratings:NA Phone: (615) 284-5555 |
Tristar Centennial Medical Center Acute Care Hospital (Medicare Certified) Location: 2300 Patterson Street, Nashville, Tennessee 37203 Ratings: Phone: (615) 342-1000 |
Tristar Southern Hills Medical Center Acute Care Hospital (Medicare Certified) Location: 391 Wallace Rd, Nashville, Tennessee 37211 Ratings: Phone: (615) 781-4000 |
Saint Thomas Hospital For Spinal Surgery Acute Care Hospital (Medicare Certified) Location: 2011 Murphy Avenue, Nashville, Tennessee 37203 Ratings:NA Phone: (615) 515-8200 |
Middle Tn Mental Health Institute Psychiatric Hospital (Medicare Certified) Location: 221 Stewarts Ferry Pike, Nashville, Tennessee 37214 Ratings:NA Phone: (615) 902-7565 |
News Archive
Synpromics Ltd, a leading synthetic biology company, and The Cell Therapy Catapult, the UK organisation accelerating the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, today announce the launch of a collaboration to remove a major barrier to the development of the cell and gene therapy industry by reducing the cost and increasing the scale and efficiency of viral vector manufacturing.
A new approach to stimulating immune cells enhances their anticancer activity, resulting in a powerful anti-tumor response in mice, according to a study by researchers at the National Cancer Institute, a part of the National Institutes of Health. This work represents an important advance in the development of immunotherapy for cancer and appears online June 14, 2009 in Nature Medicine.
FSC Therapeutics, LLC, today announced that the Company has entered into a transaction with Eisai Inc. to acquire exclusive U.S. marketing rights for AcipHex® Sprinkle™ (rabeprazole sodium), Delayed-Release Capsules, 5 mg and 10 mg, for the treatment of Gastroesophageal Reflux Disease (GERD) in children 1 to 11 years of age for up to 12 weeks.
Researchers from the University of Missouri have found a more accurate laboratory method for diagnosing pancreatic cancer, the fourth leading cause of cancer death in the United States. The disease causes more than 38,000 deaths each year in the United States, and kills 94 percent of people with the illness within five years, according to the National Cancer Institute.
› Verified 4 days ago